Karin GroschCMC Regulatory Affairs Director at AstraZenecaSpeaker
Profile
Karin Grosch is a CMC (Chemistry Manufacturing and Control) Regulatory Affairs Director at AstraZeneca, Sweden, with over 20 years of experience in the pharmaceutical industry. Throughout her career, Karin has held various roles in Quality and Regulatory Affairs. For the past 15 years, she has specialized in regulatory CMC requirements, focusing on marketing applications and post-approval submissions. Karin has a wide range of experience in the strategic aspects of global marketing applications and currently leads regulatory CMC activities for AstraZeneca's commercial oligonucleotide program. She holds a MSc in Pharmacy from Uppsala University, Sweden. |
Agenda Sessions
Oligonucleotide Odyssey: Regulatory CMC Insights from Recent Global Filings
, 11:15View Session